J. W. Coons Advisors LLC Sells 195 Shares of CVS Health Co. (NYSE:CVS)

J. W. Coons Advisors LLC lessened its stake in shares of CVS Health Co. (NYSE:CVS) by 0.6% during the 3rd quarter, Holdings Channel reports. The fund owned 34,320 shares of the pharmacy operator’s stock after selling 195 shares during the period. J. W. Coons Advisors LLC’s holdings in CVS Health were worth $2,158,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in CVS. Livelsberger Financial Advisory purchased a new position in CVS Health in the third quarter valued at about $31,000. Reston Wealth Management LLC bought a new position in shares of CVS Health during the 3rd quarter worth approximately $32,000. First Community Trust NA boosted its stake in CVS Health by 116.2% in the second quarter. First Community Trust NA now owns 562 shares of the pharmacy operator’s stock valued at $33,000 after acquiring an additional 302 shares in the last quarter. Kathleen S. Wright Associates Inc. purchased a new position in CVS Health in the third quarter worth $33,000. Finally, ORG Partners LLC increased its position in shares of CVS Health by 11,840.0% during the second quarter. ORG Partners LLC now owns 597 shares of the pharmacy operator’s stock worth $35,000 after purchasing an additional 592 shares in the last quarter. 80.66% of the stock is currently owned by hedge funds and other institutional investors.

CVS Health Stock Down 3.4 %

Shares of CVS opened at $53.19 on Monday. The stock has a 50 day moving average price of $59.23 and a 200 day moving average price of $58.60. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.59 and a current ratio of 0.80. The stock has a market capitalization of $66.93 billion, a price-to-earnings ratio of 13.50, a PEG ratio of 0.92 and a beta of 0.55. CVS Health Co. has a one year low of $52.71 and a one year high of $83.25.

CVS Health (NYSE:CVS) last released its earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.08 by $0.01. The business had revenue of $95.43 billion during the quarter, compared to analyst estimates of $92.72 billion. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The company’s revenue for the quarter was up 6.3% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $2.21 earnings per share. Equities research analysts forecast that CVS Health Co. will post 5.48 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, November 1st. Shareholders of record on Monday, October 21st were paid a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a yield of 5.00%. The ex-dividend date of this dividend was Monday, October 21st. CVS Health’s dividend payout ratio (DPR) is 67.51%.

Wall Street Analysts Forecast Growth

Several research analysts recently weighed in on CVS shares. Evercore ISI boosted their target price on CVS Health from $62.00 to $75.00 and gave the stock an “outperform” rating in a research note on Tuesday, October 8th. Deutsche Bank Aktiengesellschaft decreased their price objective on shares of CVS Health from $64.00 to $63.00 and set a “hold” rating for the company in a research report on Friday, August 9th. StockNews.com cut shares of CVS Health from a “hold” rating to a “sell” rating in a report on Thursday. TD Cowen raised shares of CVS Health from a “hold” rating to a “buy” rating and boosted their price objective for the company from $59.00 to $85.00 in a report on Friday, October 4th. Finally, UBS Group raised their target price on CVS Health from $60.00 to $62.00 and gave the stock a “neutral” rating in a research note on Thursday, November 7th. One investment analyst has rated the stock with a sell rating, eight have given a hold rating and twelve have given a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $72.44.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.